- Stem cells that prevent birth defect also repair facial injury
- UAlberta research reveals new possibilities for islet and stem cell transplantation
- Drugs stimulate body’s own stem cells to replace brain cells lost in multiple sclerosis
- New transitional stem cells discovered
- Stem cell injection may soon reverse vision loss due to age-related macular degeneration
- U-M researchers find new gene involved in blood-forming stem cells
- Stem cell disease model clarifies bone cancer trigger
- Moffitt researchers discover novel mechanism controlling lung cancer stem cell growth
Researchers have pinpointed a primary cause of a rare skull disorder in infants, and the discovery could help wounded soldiers, car-wreck victims and other patients recover from disfiguring facial injuries.
James Shapiro, one of the world’s leading experts in emerging treatments of diabetes, can’t help but be excited about his latest research. The results he says, could soon mark a new standard for treatment–not only in diabetes, but in several other diseases as well.
A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Pre-eclampsia is a disease that affects 5 to 8 percent of pregnancies in America. Complications from this disease can lead to emergency cesarean sections early in pregnancies to save the lives of the infants and mothers. Scientists believe pre-eclampsia is caused by a number of factors, including shallow placentas that are insufficiently associated with maternal blood vessels. Now, researchers from the University of Missouri, in an effort to grow placenta cells to better study the causes of pre-eclampsia, serendipitously discovered a previously unknown form of human embryonic stem cell.
An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65.
Research led by the University of Michigan Life Sciences Institute has identified a gene critical to controlling the body’s ability to create blood cells and immune cells from blood-forming stem cells–known as hematopoietic stem cells.